Compounds > dihydroresveratrol
Page last updated: 2024-09-05

dihydroresveratrol and 3,4,4'-trihydroxy-trans-stilbene

dihydroresveratrol has been researched along with 3,4,4'-trihydroxy-trans-stilbene in 1 studies

Compound Research Comparison

Studies
(dihydroresveratrol)		Trials
(dihydroresveratrol)		Recent Studies (post-2010)
(dihydroresveratrol)		Studies
(3,4,4'-trihydroxy-trans-stilbene)		Trials
(3,4,4'-trihydroxy-trans-stilbene)		Recent Studies (post-2010) (3,4,4'-trihydroxy-trans-stilbene)
35227603

Protein Interaction Comparison

ProteinTaxonomydihydroresveratrol (IC50)3,4,4'-trihydroxy-trans-stilbene (IC50)
Ribosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)6

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dai, Y; Kogure, Y; Mabuchi, M; Nakao, S; Noguchi, K; Shimizu, T; Tanaka, A; Wang, S1

Other Studies

1 other study(ies) available for dihydroresveratrol and 3,4,4'-trihydroxy-trans-stilbene

ArticleYear
Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
    Bioorganic & medicinal chemistry letters, 2017, 07-15, Volume: 27, Issue:14

    Topics: Analgesics; Animals; Calcium Channels; Ganglia, Spinal; HEK293 Cells; Humans; Inhibitory Concentration 50; Nerve Tissue Proteins; Pain; Patch-Clamp Techniques; Rats; Resveratrol; Stilbenes; Transient Receptor Potential Channels; TRPA1 Cation Channel

2017